Search All Jobs

Showing 2 of 2 Jobs

Director-Servicenow Product Architect for HR products

Chennai, Tamil Nadu, India

Employee Relations Partner

$114.8k - $171.3k/yr

Gaithersburg, MD, USA

Full-Time

Director-Servicenow Product Architect for HR products

Confirmed live in the last 24 hours

AstraZeneca

AstraZeneca

10,001+ employees

Develops and commercializes prescription medicines

No salary listed

Senior, Expert

Chennai, Tamil Nadu, India

In-person working gives us the platform we need to connect, work at pace and challenge perceptions. We work, on average, a minimum of three days per week from the office, but we balance this with individual flexibility.

Category
Human Resources
People & HR
Required Skills
JavaScript
ServiceNow
Bootstrap
HTML/CSS
Requirements
  • Familiarity with ServiceNow, especially in Human Resource Service Delivery (HRSD) and Workplace Service Delivery (WSD)
  • Strong problem-solving skills with the ability to think strategically and drive sophisticated projects from feasibility to completion
  • Excellent communication skills with the ability to engage and influence collaborators at all levels
  • Ability to deliver solutions that provide best in class user experience with a focus on ease of use, logical process flows, accessibility and productivity
  • Experience in analyzing business processes, creating workflow diagrams, and documenting requirements in a clear and concise manner
  • Certified ServiceNow Technical Master Architect
  • ServiceNow Implementation Specialist – HR Service Delivery (HRSD)
  • ServiceNow Certified System Administrator
  • Ability to influence senior leaders and collaborators, providing clear recommendations that address business and technical challenges in Human Resource & Site Operations service delivery contexts
  • Proficiency in creating architectural designs, solution presentations, and integration strategies, particularly within Employee Workflow environments
  • Experience with Web Technologies (XML, HTML, JavaScript, Web Services, Bootstrap, CSS)
Responsibilities
  • Embrace and drive a culture of accountability for customer and business outcomes
  • Serve as the technical advocate for ServiceNow HRSD & WSD solutions
  • Possess passion and experience as an individual contributor, responsible for the engineering designs and technical feasibility of solutions
  • Develop lean engineering solutions through rapid, inexpensive experimentation to tackle customer needs
  • Exhibit an attitude that favors action and evidence over extensive planning
  • Work collaboratively with empowered, multi-functional teams
  • Possess deep expertise in modern software engineering practices and principles
  • Quickly acquire domain-specific knowledge relevant to the business or implemented ServiceNow modules
  • Exhibit exceptional communication skills, capable of articulating sophisticated technical concepts clearly and compellingly
  • Engage and collaborate with collaborators at all organizational levels
Desired Qualifications
  • 8+ years of experience in ServiceNow HRSD & WSD solutioning and ServiceNow administration
  • Overall experience of 10+ years
  • Experience in leveraging or critically thinking about how to integrate AI into work processes, decision-making, or problem-solving
  • Experience using AI-powered tools, automating workflows, analyzing AI-driven insights, or exploring AI

AstraZeneca develops and sells prescription medicines, focusing on three main areas: Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Their products are created through extensive research and development, which includes clinical trials and regulatory approvals. Unlike competitors, AstraZeneca emphasizes collaboration through its Open Innovation program and the A.Catalyst Network, connecting health innovation hubs worldwide. The company's goal is to advance healthcare by providing effective treatments for serious diseases.

Company Size

10,001+

Company Stage

IPO

Headquarters

Cambridge, United Kingdom

Founded

1913

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven drug discovery enhances AstraZeneca's R&D efficiency and innovation.
  • Real-world evidence supports AstraZeneca's drug efficacy and safety demonstrations.
  • Personalized medicine aligns with AstraZeneca's focus on precision therapies.

What critics are saying

  • Class-action lawsuit over Soliris could lead to legal costs and reputational damage.
  • AI tool for breast cancer screening may face challenges in minority representation.
  • Foreign investment regulations in France may impact AstraZeneca's Dunkirk expansion.

What makes AstraZeneca unique

  • AstraZeneca excels in oncology, cardiovascular, and respiratory therapeutic areas.
  • The A.Catalyst Network fosters global collaboration and innovation in healthcare.
  • Open Innovation program accelerates drug discovery by sharing compounds and technologies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Flexible Work Hours

Company News

Cision
Apr 22nd, 2025
Enhertu Combination Improved Pfs In 1L Her2+ Mbc

Enhertu combination improved PFS in 1L HER2+ mBC

Life Sciences IP Review
Apr 17th, 2025
AstraZeneca unit faces class-action suit over alleged Soliris monopoly

AstraZeneca unit faces class-action suit over alleged soliris monopoly.

Our Health Needs
Apr 11th, 2025
Study: Racial, ethnic minorities are underrepresented in AI mammogram interpretation

In 2024, AI biotech company Owkin partnered with pharma giant AstraZeneca to develop an AI-powered tool designed to pre-screen for gBRCA mutations (gBRCAm) in breast cancer directly from digitized pathology slides.

Medical Update Online
Apr 11th, 2025
AstraZeneca showcases progress in immunisation and real-world evidence addressing global infectious disease burden at ESCMID Global 2025

AstraZeneca showcases progress in immunisation and real-world evidence addressing global infectious disease burden at ESCMID Global 2025.

Cision
Apr 11th, 2025
Result Of Agm

11 April 2025Results of Annual General Meeting held on 11 April 2025AstraZeneca PLC announced the results of the voting at its Annual General Meeting (AGM) today. As proposed in the Notice of AGM, all Resolutions were decided by poll vote. Resolutions 9 - 12 were passed as special resolutions; all other resolutions were passed as ordinary resolutions.Resolution. Votes for. % of votes cast